Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes

Abstract

Vascular endothelial dysfunction is an early marker of atherosclerosis seen in type 2 diabetes (T2DM). Circulating endothelial progenitor cell (EPC) is involved in the neovasculogenesis and maintenance of vascular homeostasis, whose impairment may have an important role in the pathogenesis of diabetic vasculopathy. This study was performed to investigate the relationship between vascular endothelial function and circulating EPC number in T2DM. A total of 46 newly diagnosed T2DM patients (DM group) and 51 healthy subjects (NG group) were recruited. Metformin was administered to all patients for 16 weeks. Endothelial function was assessed by flow-mediated brachial artery dilatation (FMD). EPC was defined by CD45^low/CD34⁺/VEGFR2⁺ and quantified by flow cytometry. The EPC number in the DM group was significantly lower than that in the NG group (p < 0.001), and improved markedly after treatment (p < 0.001). The results of FMD were consistent with EPC variations among the three groups (p < 0.001). In multivariate regression analysis, the EPC number was an independent risk factor for FMD at baseline (p < 0.05). The absolute changes of EPC number showed significant correlation with the changes of FMD before and after treatment (r = 0.63, p < 0.001). This study demonstrated that the circulating EPC number was related to endothelial function and could be considered as a surrogate biological marker of endothelial function for T2DM.

Keywords

endothelial function endothelial progenitor cell flow-mediated dilatation type 2 diabetes

References

Creager MA , Lüscher TF , Cosentino F. , et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003 ; 108: 1527-1532.

Tooke JE , Goh KL Vascular function in type 2 diabetes mellitus and pre-diabetes: the case for intrinsic endotheiopathy. Diabet Med 1999; 16: 710-715.

Grover-Páez F. , Zavalza-Gómez AB Endothelial dysfunction and cardiovascular risk factors. Diabetes Res Clin Pract 2009; 84: 1-10.

Cohn JN , Quyyumi AA , Hollenberg NK , et al. Surrogate markers for cardiovascular disease: functional markers . Circulation 2004; 109: 31-46.

Rafii S. , Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702-712.

Rosenzweig A. Circulating endothelial progenitors - cells as biomarkers. N Engl J Med 2005;353:1055-1057.

Fadini GP , Sartore S. , Baesso I. , et al. Endothelial progenitor cells and the diabetic paradox. Diabetes Care 2006; 29: 714-716.

Fadini GP , Sartore S. , Albiero M. , et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006; 26: 2140-2146.

Tepper OM , Galiano RD , Capla JM , et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures . Circulation 2002; 106: 2781-2786.

10.

Fadini GP , Agostini C. , Avogaro A. Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives. Curr Diabetes Rev 2005; 1: 41-58.

11.

Werner N. , Wassmann S. , Ahlers P. , et al. Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 2007; 102: 565-571.

12.

Wang CH , Ting MK , Verma S. , et al. Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance. Diabetes Care 2006; 29: 1083-1089.

13.

Davis BJ , Xie Z. , Viollet B. , et al. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 2006; 55: 496-505.

14.

UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.

15.

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.

16.

Werner N. , Kosiol S. , Schiegl T. , et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.

17.

Kim W. , Jeong MH , Cho SH , et al. Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers. Circ J 2006; 70: 1052-1057.

18.

Xiang GD , Xu L. , Zhao LS , et al. The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes. Diabetes 2006; 55: 2126-2131.

19.

Avogaro A. , Toffolo G. , Kiwanuka E. , et al. L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach. Diabetes 2003; 52: 795-802.

20.

Verma S. , Anderson TJ Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002; 105: 546-549.

21.

Thum T. , Bauersachs J. Spotlight on endothelial progenitor cell inhibitors: short review. Vasc Med 2005; 10(suppl 1): S59-64.

22.

Vasa M. , Fichtlscherer S. , Aicher A. , et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7.

23.

Schmidt-Lucke C. , Rossig L. , Fichtlscherer S. , et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-2987.

24.

Hill JM , Zalos G. , Halcox JP , et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003 ; 348: 593-600.

25.

Thum T. , Fraccarollo D. , Schultheiss M. , et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 2007; 56: 666-674.

26.

Wang CH , Ciliberti N. , Li SH , et al. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 2004; 109: 1392-1400.

27.

Imanishi T. , Hano T. , Nishio I. Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertens Res 2004; 27: 101-108.